 - Disease measurable or evaluable as defined by RECIST 1.1, a mass of greater than 1cm in the long axis andor other tumor response criteria from an MSKCC IRB-approved clinical research protocol. NOTE: Study patients do not need to be participating in an MSKCC approved clinical trial prior to study recruitment. 